Neural Therapeutics

Neural Therapeutics Ethnobotanical drug discovery company focused on R&D of mescaline-containing cacti.

Neural’s Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich - https://mailchi.mp/neuraltherap...
09/24/2025

Neural’s Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich - https://mailchi.mp/neuraltherapeutics/neurals-partner-hanfcom-expands-retail-footprint-with-17th-store-opening-near-munich

We are pleased to announce that Neural’s partner Hanf.com announced opening of its 17th store near Munich. As disclosed in Neural's press release dated August13, 2025, Neural owns a 30.75% interest in CWE with an option to acquire the remaining69.25% upon satisfaction of certain conditions.

Neural Therapeutics Strengthens IP Portfolio with a Patent Application -
04/14/2025

Neural Therapeutics Strengthens IP Portfolio with a Patent Application -

We are pleased to announce that Neural Therapeutics announced a filing of a patent application, change of ticker on Frankfurt Stock Exchange from “M6B” to “HANF”, and extension of the Letter of Intent with CWE European Holdings Inc. (dba Hanf.com). The press release is included below.

Neural Therapeutics is Now Listed on the CSE under the symbol NURL -
03/17/2025

Neural Therapeutics is Now Listed on the CSE under the symbol NURL -

We are thrilled to announce that Neural Therapeutics is commencing trading today on the Canadian Securities Exchange (CSE) under the symbol “NURL”. You are invited to view Neural’s CSE by clicking here. The press release announcing trading, updates on growth and engagement of investor relation...

Neural Therapeutics Announces Closing of Financing, CSE Listing Approval and Corporate Updates -
03/14/2025

Neural Therapeutics Announces Closing of Financing, CSE Listing Approval and Corporate Updates -

We are thrilled to announce that Neural Therapeutics closed the final tranche of its private placement for total proceeds of $518,500. This completed the final exchange requirements, and consequently we received CSE Listing Approval. Our press release is included below, and the Company expects listi...

Neural Therapeutics Announces LOI to Acquire "HANF.COM" Leading German H**p Product Retailer - https://mailchi.mp/neural...
10/03/2024

Neural Therapeutics Announces LOI to Acquire "HANF.COM" Leading German H**p Product Retailer - https://mailchi.mp/neuraltherapeutics/neural-therapeutics-receives-conditional-approval-to-list-on-the-cse-and-announces-concurrent-financing-18114164

We are thrilled to announce that Neural Therapeutics entered into letter of intent to acquire “Hanf.com”, a leading German hemp-based product retailer with 12 locations in the State of Bavaria. According to the preliminary unaudited internal financial estimates, Hanf.com is on track to achieve t...

Invitation: Neural Therapeutics Corporate Update Webcast with Ian Campbell -
06/18/2024

Invitation: Neural Therapeutics Corporate Update Webcast with Ian Campbell -

We wish to cordially invite our loyal stakeholders, investors and business partners to a Neural Therapeutics corporate update webcast at 12:00PM EST on Thursday June 20, 2024.

Neural Therapeutics Receives Conditional Approval to List on the CSE and Announces Concurrent Financing -
05/08/2024

Neural Therapeutics Receives Conditional Approval to List on the CSE and Announces Concurrent Financing -

We are thrilled to announce that Neural Therapeutics has received Conditional Approval to list on Canadian Securities Exchange under the ticker “NURL”. The principal condition to list is to the completion of a financing of CAD $500,000 CAD, among other requirements. The related press release is ...

Neural Therapeutics Shareholder Update from CEO Ian Campbell -
02/17/2024

Neural Therapeutics Shareholder Update from CEO Ian Campbell -

I hope this message finds you well. I am pleased to provide you with the latest updates on our company's progress and key developments. As we navigate the dynamic landscape of the psychedelic medicine industry, Neural Therapeutics remains committed to driving innovation and making a meaningful impac...

Introducing: Neural Therapeutics Online Magazine -
08/11/2023

Introducing: Neural Therapeutics Online Magazine -

As a valued member of our stakeholder community, we would like to introduce you to our free on-line magazine, Neural Therapeutics Magazine. You may join by scanning the QR code below on your phone or tablet or click the corresponding link.

Neural Therapeutics Receives SERFOR Permit in Peru -
07/27/2023

Neural Therapeutics Receives SERFOR Permit in Peru -

We are pleased to announce that Neural has received a key permit in Peru, issued by the National Service for Forest and Wildlife, part of Peru’s Ministry of Agriculture. This permit provides the Company with access to genetic resources and their derivatives for the evaluation of the mescaline-cont...

Address

77 King Street West, Suite 2905
Toronto, ON
M5K1H1

Website

Alerts

Be the first to know and let us send you an email when Neural Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Neural Therapeutics:

Shortcuts

Share

Category